Browse complete Report Pharmaceutical Pricing and Reimbursement – Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies
Browse all GBI Research Market Research Reports
GBI Research, the leading business intelligence provider, has released its latest research, “Pharmaceutical Pricing and Reimbursement – Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies”. It provides key data, information and analysis of the major issues affecting the pricing and reimbursement decisions across the globe. It discusses the major changes that have been observed in the pharmaceutical and healthcare industry at the global level. The report also covers issues specific to particular geographies. The geographies covered include the US and countries within Western Europe, Asia-Pacific, Central and Eastern Europe, and Scandinavia. It covers pricing and reimbursement mechanisms in different countries as well as the impact of issues on the key stakeholders. The report puts a special emphasis on orphan drugs since the pricing and reimbursement patterns for orphan drugs are different from the traditional mechanisms.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.
Scope
The scope of this report includes:
- Identification and analysis of major issues that are affecting the pricing and reimbursement decisions across five different geographies. These include North America, Western Europe, Asia-Pacific, Central and Eastern Europe and Scandinavia
- Analysis of the issues and potential impact of pricing and reimbursement decisions on the key stakeholders
- Study of the pricing and reimbursement mechanisms in different countries and the identification of trends in the context of a particular geography as a whole
- Qualitative analysis of the forces that are driving and restraining the prices and reimbursements within a particular geography
- Future outlook of the pricing and reimbursement patterns for geographies under consideration
Reasons to buy
The report will enhance your decision making and will enable you to:
- Build understanding of the major issues in the pricing and reimbursement landscape
- Identify the impact of each issue on your business and develop solutions for adverse impacts
- Negotiate better with the government agencies to maximize the reimbursement on the drugs by understanding the pricing and reimbursement mechanism
- Develop effective business strategies for pricing a drug which is to be launched in any of the markets considered in this report
- Identify and exploit the factors that could help to maximize returns on the drugs for a particular geography in future
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Original Source: Pharmaceutical Pricing and Reimbursement Market
Buy Now: Market Research
